| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Dockendorff Charles J is a Director at Keysight Technologies, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 2 buys and 7 sells.
Estimated insider holdings value: $20.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | BSX Boston Scientific Corp | Director | Sell | 3,946 | $72.70 | $286,874.20 | -100% | -0.6% | +42.7% | |
| Mar 8, 2024 | HOLX Hologic Inc | Director | Sell | 1,465 | $76.21 | $111,647.65 | -48.2% | -2.9% | -16.2% | |
| Jan 2, 2024 | HOLX Hologic Inc | Director | Sale+OE | 16,017 | $72.00 | $1,153,224.00 | -91.6% | +5.1% | -1.0% | |
| Sep 5, 2023 | HAE Haemonetics Corp | Director | Sell | 10,215 | $87.68 | $895,651.20 | -82.1% | -4.5% | -14.0% | |
| Aug 18, 2023 | BSX Boston Scientific Corp | Director | Sell | 17,079 | $50.74 | $866,631.16 | -81.2% | +8.9% | +55.9% | |
| Dec 13, 2022 | KEYS Keysight Technologies, Inc. | Director | Sell | 3,257 | $185.06 | $602,753.12 | -5.8% | -16.7% | -17.8% | |
| Feb 4, 2021 | HAE Haemonetics Corp | Director | Sale+OE | 12,180 | $134.53 | $1,638,575.40 | -47.0% | - | - | |
| Mar 15, 2018 | HOLX Hologic Inc | Director | Buy | 13,000 | $38.80 | $504,400.00 | +272.2% | - | - | |
| Jun 9, 2017 | KEYS Keysight Technologies, Inc. | Director | Buy | 13,210 | $37.81 | $499,470.10 | +34.2% | - | - |